Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.

作者: Joëlle Siat , Christian Bronner , Nadine Martinet , Jacques Borrelly , Philippe Scheid

DOI:

关键词:

摘要: … markers present in the tumor cells as prognostic factors and/or … with solitary brain metastasis removed before lung surgery. … , located on chromosome 17 q21, encodes for a 185-kDa …

参考文章(32)
Karlan B, Plummer Sj, Casey G, Ramos Jc, Shaughnessy M, Lopez Me, Arboleda Mj, Slamon Dj, DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene. ,vol. 13, pp. 1971- 1981 ,(1996)
R. Rosell, J. Maestre, A. Ariza, A. Barnadas, M. Canela, E. Tolosa, J. L. Mate, P. Armengol, Z. Skacel, Shanrong Li, Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene. ,vol. 8, pp. 2407- 2412 ,(1993)
Jun-ichi Ogawa, Shirosaku Koide, Hiroshi Inoue, Expression of α-1,3-Fucosyltransferase Type IV and VII Genes Is Related to Poor Prognosis in Lung Cancer Cancer Research. ,vol. 56, pp. 325- 329 ,(1996)
John C. Reed, Double identity for proteins of the Bcl-2 family Nature. ,vol. 387, pp. 773- 776 ,(1997) , 10.1038/42867
Raymond A. Yesner, James D. Cox, Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. The American review of respiratory disease. ,vol. 120, pp. 1025- 1029 ,(1979) , 10.1164/ARRD.1979.120.5.1025
D. Dev, S. Capewell, R. Sankaran, D. Lamb, M.F. Sudlow, Adenocarcinoma of the lung — clinical features and survival Respiratory Medicine. ,vol. 90, pp. 333- 337 ,(1996) , 10.1016/S0954-6111(96)90128-6
Francesco Pezzella, Helen Turley, Isinzu Kuzu, Mohammed Fahim Tungekar, Michael S. Dunnill, Chris B. Pierce, Adrian Harris, Kevin C. Gatter, David Y. Mason, bcl-2 Protein in Non-Small-Cell Lung Carcinoma The New England Journal of Medicine. ,vol. 329, pp. 690- 694 ,(1993) , 10.1056/NEJM199309023291003
J A Kern, R J Slebos, B Top, S Rodenhuis, D Lager, R A Robinson, D Weiner, D A Schwartz, C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. Journal of Clinical Investigation. ,vol. 93, pp. 516- 520 ,(1994) , 10.1172/JCI117001
Clifton F. Mountain, A new international staging system for lung cancer Chest. ,vol. 89, pp. 225- 233 ,(1986) , 10.1378/CHEST.89.4_SUPPLEMENT.225S
Gary M. Strauss, PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCER Hematology-oncology Clinics of North America. ,vol. 11, pp. 409- 434 ,(1997) , 10.1016/S0889-8588(05)70441-X